In addition to offering a real-time, non-invasive replacement for standard laboratory blood analysis, wearable chemical sensors are a powerful tool for uncovering new biomarkers in alternative bodily fluids such perspiration, saliva, tears, and interstitial fluid. These gadgets may make remote, at-home health monitoring possible and greatly lower healthcare expenditures.
The criteria, approaches, and technology involved in biomarker identification utilising wearable chemical sensors are introduced in this review. Wearable chemical sensors’ materials and system-level issues are covered along with electrochemical and optical detection methods.
Last but not least, this Article explains how the vast temporal data sets amassed by wearable sensors, when combined with contemporary data processing techniques, might pave the way for the discovery of new biomarkers for precision medicine. In people who are ill, specific biomarker levels will be higher or lower than usual.
The development of precise illness diagnosis, treatment, and preventative techniques in medicine is intimately tied to the development of biomarkers. In order to forecast the onset and progression of a disease and to create potent treatment medications, it is crucial to find novel biomarkers.
While developing a prospective biomarker, it can be challenging to evaluate and confirm the efficacy of the biomarker candidate in a given health condition due to the lack of established protocols for sample collection, storage, and analytical procedures. Participants in biomarker discovery studies typically have to put up with invasive procedures and frequent hospital visits.
GLOBAL WEARABLE CHEMICAL SENSOR MARKET SIZE AND FORECAST
The Global Wearable chemical sensor market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
NEW PRODUCT LAUNCH
the most recent launch from IDTechEx report on wearable chemical sensors. Ultimately, IDTechEx sheds light on the potential long-term societal integration of wearable sensors, the technology that underpins the value of the “quantified self” movement.
Digital health and remote patient monitoring, extended reality, the metaverse, and performance analytics of athletes and sportspeople have been recognised as the primary growth drivers. This report discusses these meta-trends and others.Diabetics can now more frequently check their glucose levels without having to prick their fingers thanks to chemical sensors.
Commercial devices, however, still need a needle to be implanted beneath the skin’s surface. As a result, researchers continue to look for less intrusive wearable sensors. In the most recent study, a market overview for continuous glucose marketing is given, followed by a review of rival technologies that make use of microneedles and other physiological fluids.
A on new biometrics, with an emphasis on hydration, alcohol, and lactate, follows. This evaluates the possibilities for chemical sensor companies outside of the diabetes treatment arena.
THIS REPORT WILL ANSWER FOLLOWING QUESTIONS
© Copyright 2017-2023. Mobility Foresights. All Rights Reserved.